Market Overview

Atara Biotherapeutics (NASDAQ: ATRA)

13.21 +0.10 (0.76%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/08/19JP MorganDowngradesNeutral22.0
9/27/19Goldman SachsDowngradesSell9.0
9/16/19JefferiesDowngradesHold15.0
6/04/19CitigroupUpgradesNeutral
5/30/19Roth CapitalInitiates Coverage OnBuy30.0
5/23/19Stifel NicolausInitiates Coverage OnBuy41.0
1/23/19MizuhoInitiates Coverage OnBuy62.0
6/11/18CitigroupMaintainsSell23.0
4/10/18JP MorganInitiates Coverage OnOverweight56.0
3/16/18GuggenheimInitiates Coverage OnNeutral

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter